TSE:MFC

Manulife Financial (MFC.TO)

53.50
+0.47 (0.89%)
as of Jun 4, 2026, 8:00:00 pm Market Open.
1636 watching
0
Investor Insights
star iconJun 4, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC-T) presents a mixed outlook among experts, with many pointing to its strong capital position, healthy growth in Asia, and attractive dividend yield as positives. Some analysts highlight a recent dip due to earnings concerns, yet the overall sentiment leans toward the belief that MFC is fundamentally sound, especially with its strategic initiatives in wealth management and the Asian market. However, there is caution about potential market volatility and the necessity for macroeconomic factors to shift positively for the stock to reach new heights. The company is seen as a reliable income stock rather than a growth play, with its valuation being reasonable in comparison to peers, although many believe it may be undervalued relative to its long-term potential.

consensus icon
Consensus
Hold
valuation icon
Valuation
Fair Value
review icon
Similar
GWO
Unspecified

It pays a 5.8% dividend and has a low valuation probably because investors are worried about its exposure to commercial real estate which is $14 billion of its $47 billion market cap. A high percentage of this is office towers.

BUY

Excellent company, owns shares in company.
~5% dividend yield.
Growing middle class & population in Canada will require insurance.
Rising interest rates will decrease liabilities (good for business).

TRADE

Doesn't own any lifecos right now. Asian demographics are advantageous. Canada is slow and a steady eddy. Doesn't particularly like US John Hancock business. Tantalizing dividend yield, but shares never seem to be able to break out of a range. Trade, not a long-term investment.

BUY

Book value is $30, and it's trading below that, so you have a chance to buy it below book value. Great dividend yield. Great business in Asia is undervalued and will continue to grow. Interest rates help. Fundamentals are really strong.

BUY

Up 7.7% total return over the last 12 months. Trades below book value. As Asia continues to grow, MFC is poised to do very well long term. Resistance around $28, but if it can break through that, it will do well and you get paid to wait. Great yield of 5.6%.

BUY

Asian franchise gives it good growth potential, and that area of the world is growing faster than the others. High quality. Very well managed. Good dividend yield.

BUY

Has been a top pick of his many times. Insurers report in the coming week and it will be a confusing quarter, because there are new reporting/accounting rules that will make earnings appear lower. SLF and Industrial Alliance have more weighting in Asia than MFC, so MFC might be less stable. Likes MFC. Pays a 5.4% dividend yield.

BUY

Stable, core holding. Diversifies away from concern over banks' loan losses. Issues with US legacy businesses. Likes Asian insurance operations, will drive earnings for the long term. Yield is 5.5%.

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
(A Top Pick Mar 23/23, Up 7.4%)Stockchase Research Editor: Michael O'Reilly

Our PAST TOP PICK with MFC is progressing well.  To remain disciplined, we recommend trailing up the stop (from $21) to $24 at this time. 

HOLD

Performing pretty well. Big reopening in Asia is encouraging. Reasonable valuation. Dividend growth will continue. He prefers the P&C business as more rewarding than life insurance.

RISKY
Caller frustrated by MFC performance

The chart had a decent upward move from October to early March, but has fallen since. Has now returned to its $24 December base. Is widely held by large institutions and pension funds. More than other insurers, MFC is so tied to the S&P. $24 is good to buy, but if that breaks, MFC could fall to $20.

TOP PICK

Believes shares presenting good buying opportunity with fallout from Silicon Valley  Bank.
Strong management with large asset base (over $1.3 Trillion).
Higher interest rates are beneficial for insurance companies.
Aging global population will generate demand for wealth management services.
Trading at discount to net book value.
Paying ~5.9% dividend yield that is secure.

premiumPremium content

Unlock this Panic-proof Portfolio opinion with Stockchase Premium

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
Stockchase Research Editor: Michael O’Reilly

Persistent higher interest rates help profitability. The company is well positioned to offer boomers wealth management services and they have diversified geographically.  It presently trades at 8x earnings and under book value.  The dividend is good and backed by a payout ratio under 40% of cash flow.  We recommend a stop-loss at $21, looking to achieve $29 — upside potential of 18%.  Yield 5.4%

DON'T BUY

Organization that not able to generate real returns for a long time.
Would avoid buying company.
Dividend yield not worth investing in.
Better names in the sector to own.

BUY ON WEAKNESS

Hold, or trade out at historic range top of around $27?

Forging a triple top. Lifecos in general have had a strong run, now taking a breather. Financials are getting hit hard today. Longer term, chart looks great. Great dividend. Add on weakness over the coming week or so. 

Showing 121 to 135 of 2,279 entries